首页> 外文会议>International Conference and Exhibition on Pharmaceutical, Nutraceutical and Cosmeceutical Technology >Cholic Acid-Modified Poiyethylenimine for Gene Delivery into Human Carcinoma Cells
【24h】

Cholic Acid-Modified Poiyethylenimine for Gene Delivery into Human Carcinoma Cells

机译:胆碱酸改性的poiyethylenimine用于基因递送到人癌细胞中

获取原文

摘要

Poiyethylenimine (PEI) was modified by cholic acid at a molar ratio of 1:1. Cholic acid (CA)-modified PEI (PEI-CA) were evaluated for formation of DNA complexes. PEI-CA/pEGFP plasmid DNA complexes were characterized for their size and zeta potential. Gel electrophoresis showed total retardation for PEI-CA/pEGFP complexes formed at weight ratios above 0.25. The particle size and zeta potential of the complexes at a polymer-to-DNA ratio of 0.5 were 295.3 nm and 30.5 mV, respectively. The transfection efficiency of PEI-CA/pEGFP complexes was comparable to unmodified PEI. Cytotoxicity result showed that PEI-CA had lower cytoxicity than PEI. This study suggests that PEI-CA has potential utility as a gene delivery carrier.
机译:通过胆酸以1:1的摩尔比修饰Poiyethethenimine(PEI)。评价胆酸(CA)级化的PEI(PEI-CA)以形成DNA复合物。 PEI-CA / PEGFP质粒DNA复合物的特征在于它们的尺寸和Zeta电位。凝胶电泳显示PEI-CA / PEGFP配合物的总延迟,其重量比在0.25以上。聚合物与DNA比的粒径和ζ电位分别为0.5的聚合物 - DNA比和30.5mV分别为295.3nm和30.5mV。 PEI-CA / PEGFP复合物的转染效率与未修饰的PEI相当。细胞毒性结果表明,PEI-CA具有比PEI更低的细胞毒性。本研究表明,PEI-CA具有作为基因递送载体的潜在效用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号